Cytomegalovirus infection in children with Down syndrome in a day-care center in Brazil

Detalhes bibliográficos
Autor(a) principal: CANTO, Cynthia L. Motta do
Data de Publicação: 2000
Outros Autores: GRANATO, Celso F. H., GARCEZ, Elisa, VILLAS BOAS, Lucy S., FINK, M. Cristina D. S., ESTEVAM, Marli P., PANNUTI, Claudio S.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista do Instituto de Medicina Tropical de São Paulo
Texto Completo: https://www.revistas.usp.br/rimtsp/article/view/30436
Resumo: This study evaluates the transmission of CMV infection in 120 children aged 1 to 15 years with Down syndrome who attended a day-care center for handicapped children in São Paulo, Brazil. A blood sample was obtained from each children at the beginning of the study for detection of IgG and IgM cytomegalovirus (CMV) antibodies by an immunofluorescence assay. Samples of saliva and urine were obtained every 3 months from the children with CMV antibodies to detect shedding of the virus by culture in human foreskin fibroblasts, by detection of pp65 CMV-antigen and by a nested PCR assay. The prevalence of anti CMV-IgG antibodies was 76.6% (92/120), and IgM anti-CMV antibodies were detected in 13% (12/92) of the seropositive children. During the first viral evaluation, CMV was detected in the urine and/or saliva in 39/90 (43.3%) of the seropositive children. In the second and third evaluations, CMV was detected in 41/89 (46%) and in 35/89 (39.3%) children, respectively. Detection of CMV was shown both in urine and saliva in 28/39 (71.8%), 19/41(46.3%) and 20/35 (57.1%) of the children excreting the virus, respectively. Additionally, in 33/49 (67.4%) of the excreters CMV could be demonstrated in urine or saliva in at least two out of the three virological evaluations carried out sequentially in a six month period. Of the 28 initially seronegative children, 26 were re-examined for anti-CMV IgG antibodies about 18 months after the negative sample; seroconversion was found in 10/26 (38.5%). Taking all 536 samples of urine or saliva examined by virus culture and pp65 antigen detection during the study into account, 159 (29.6%) were positive by virus culture and 59 (11%) gave a positive result with the pp65 assay. These data demonstrate the high prevalence of CMV shedding and the high risk of CMV infection in children with Down syndrome attending a day-care center for mentally handicapped patients. The virus culture was more sensitive than the pp65 CMV antigen assay for CMV detection in both urine and saliva samples.
id IMT-1_e50317a506d34d3ac4f857c196d575df
oai_identifier_str oai:revistas.usp.br:article/30436
network_acronym_str IMT-1
network_name_str Revista do Instituto de Medicina Tropical de São Paulo
repository_id_str
spelling Cytomegalovirus infection in children with Down syndrome in a day-care center in Brazil Infecção por citomegalovírus em crianças institucionalizadas portadoras da síndrome de Down no Brasil CytomegaloviDown SyndrDay-care cenTransmissVirus shedd This study evaluates the transmission of CMV infection in 120 children aged 1 to 15 years with Down syndrome who attended a day-care center for handicapped children in São Paulo, Brazil. A blood sample was obtained from each children at the beginning of the study for detection of IgG and IgM cytomegalovirus (CMV) antibodies by an immunofluorescence assay. Samples of saliva and urine were obtained every 3 months from the children with CMV antibodies to detect shedding of the virus by culture in human foreskin fibroblasts, by detection of pp65 CMV-antigen and by a nested PCR assay. The prevalence of anti CMV-IgG antibodies was 76.6% (92/120), and IgM anti-CMV antibodies were detected in 13% (12/92) of the seropositive children. During the first viral evaluation, CMV was detected in the urine and/or saliva in 39/90 (43.3%) of the seropositive children. In the second and third evaluations, CMV was detected in 41/89 (46%) and in 35/89 (39.3%) children, respectively. Detection of CMV was shown both in urine and saliva in 28/39 (71.8%), 19/41(46.3%) and 20/35 (57.1%) of the children excreting the virus, respectively. Additionally, in 33/49 (67.4%) of the excreters CMV could be demonstrated in urine or saliva in at least two out of the three virological evaluations carried out sequentially in a six month period. Of the 28 initially seronegative children, 26 were re-examined for anti-CMV IgG antibodies about 18 months after the negative sample; seroconversion was found in 10/26 (38.5%). Taking all 536 samples of urine or saliva examined by virus culture and pp65 antigen detection during the study into account, 159 (29.6%) were positive by virus culture and 59 (11%) gave a positive result with the pp65 assay. These data demonstrate the high prevalence of CMV shedding and the high risk of CMV infection in children with Down syndrome attending a day-care center for mentally handicapped patients. The virus culture was more sensitive than the pp65 CMV antigen assay for CMV detection in both urine and saliva samples. O objetivo do presente estudo foi avaliar a prevalência de infecção pelo CMV em 120 crianças de 1-15 anos de idade, com síndrome de Down, que frequentavam uma instituição para atendimento de crianças portadoras de deficiência mental em São Paulo, Brasil. Uma amostra de sangue foi obtida de cada criança no início do estudo para detecção de anticorpos anti-CMV (IgG e IgM) por imunofluorescência indireta. Das crianças positivas para anticorpos IgG, 3 amostras de saliva e urina foram obtidas com intervalo de 3 meses entre elas, para detectar presença do CMV por cultura em fibroblastos humanos, detecção de antígeno pp65 do CMV ou reação em cadeia por polimerase (PCR). A prevalência de anticorpos IgG na admissão foi de 76,6% (92/120) e anticorpos IgM foram detectados em 13% (12/92) das amostras IgG positivas. Durante a primeira avaliação virológica, CMV foi detectado na urina e/ou saliva de 43,3% (39/90) das crianças soropositivas. Na segunda e terceira avaliações CMV foi demonstrado em 41/89 (46%) e 35/89 (39,3%) das crianças, respectivamente. Nestas avaliações, presença do CMV foi documentada tanto na urina quanto na saliva em 28/39 (71,8%), 19/41 (46,3%) e 20/35 (57,1%) das crianças excretoras. Além disso, 33/49 (67,4%) das crianças estavam excretando CMV na saliva ou urina em pelo menos duas das tres avaliações virológicas realizadas durante o estudo. Aproximadamente 18 meses após a primeira coleta, soroconversão para IgG anti-CMV foi documentada em 10/26 (38,5%) das crianças inicialmente soronegativas. Levando em conta todas as 536 amostras de urina ou saliva examinadas por isolamento viral e detecção de antígeno pp65 do CMV, observou-se que 159 (29,6%) foram positivas por isolamento viral e 59 (11%) foram positivas por pesquisa de antígeno pp65. Este estudo demonstra que há uma alta taxa de excreção do CMV na urina e saliva em crianças com síndrome de Down que frequentam creches, e um alto risco de infecção por este vírus em crianças susceptíveis que frequentam estas instituições. O isolamento viral mostrou-se mais sensível que a detecção de antígeno pp65 do CMV, tanto em amostras de urina quanto em amostras de saliva. Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo2000-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/rimtsp/article/view/30436Revista do Instituto de Medicina Tropical de São Paulo; Vol. 42 No. 4 (2000); 179-184 Revista do Instituto de Medicina Tropical de São Paulo; Vol. 42 Núm. 4 (2000); 179-184 Revista do Instituto de Medicina Tropical de São Paulo; v. 42 n. 4 (2000); 179-184 1678-99460036-4665reponame:Revista do Instituto de Medicina Tropical de São Pauloinstname:Instituto de Medicina Tropical (IMT)instacron:IMTenghttps://www.revistas.usp.br/rimtsp/article/view/30436/32320Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Pauloinfo:eu-repo/semantics/openAccessCANTO, Cynthia L. Motta doGRANATO, Celso F. H.GARCEZ, ElisaVILLAS BOAS, Lucy S.FINK, M. Cristina D. S.ESTEVAM, Marli P.PANNUTI, Claudio S.2012-07-07T09:35:09Zoai:revistas.usp.br:article/30436Revistahttp://www.revistas.usp.br/rimtsp/indexPUBhttps://www.revistas.usp.br/rimtsp/oai||revimtsp@usp.br1678-99460036-4665opendoar:2022-12-13T16:51:12.486272Revista do Instituto de Medicina Tropical de São Paulo - Instituto de Medicina Tropical (IMT)true
dc.title.none.fl_str_mv Cytomegalovirus infection in children with Down syndrome in a day-care center in Brazil
Infecção por citomegalovírus em crianças institucionalizadas portadoras da síndrome de Down no Brasil
title Cytomegalovirus infection in children with Down syndrome in a day-care center in Brazil
spellingShingle Cytomegalovirus infection in children with Down syndrome in a day-care center in Brazil
CANTO, Cynthia L. Motta do
Cytomegalovi
Down Syndr
Day-care cen
Transmiss
Virus shedd
title_short Cytomegalovirus infection in children with Down syndrome in a day-care center in Brazil
title_full Cytomegalovirus infection in children with Down syndrome in a day-care center in Brazil
title_fullStr Cytomegalovirus infection in children with Down syndrome in a day-care center in Brazil
title_full_unstemmed Cytomegalovirus infection in children with Down syndrome in a day-care center in Brazil
title_sort Cytomegalovirus infection in children with Down syndrome in a day-care center in Brazil
author CANTO, Cynthia L. Motta do
author_facet CANTO, Cynthia L. Motta do
GRANATO, Celso F. H.
GARCEZ, Elisa
VILLAS BOAS, Lucy S.
FINK, M. Cristina D. S.
ESTEVAM, Marli P.
PANNUTI, Claudio S.
author_role author
author2 GRANATO, Celso F. H.
GARCEZ, Elisa
VILLAS BOAS, Lucy S.
FINK, M. Cristina D. S.
ESTEVAM, Marli P.
PANNUTI, Claudio S.
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv CANTO, Cynthia L. Motta do
GRANATO, Celso F. H.
GARCEZ, Elisa
VILLAS BOAS, Lucy S.
FINK, M. Cristina D. S.
ESTEVAM, Marli P.
PANNUTI, Claudio S.
dc.subject.por.fl_str_mv Cytomegalovi
Down Syndr
Day-care cen
Transmiss
Virus shedd
topic Cytomegalovi
Down Syndr
Day-care cen
Transmiss
Virus shedd
description This study evaluates the transmission of CMV infection in 120 children aged 1 to 15 years with Down syndrome who attended a day-care center for handicapped children in São Paulo, Brazil. A blood sample was obtained from each children at the beginning of the study for detection of IgG and IgM cytomegalovirus (CMV) antibodies by an immunofluorescence assay. Samples of saliva and urine were obtained every 3 months from the children with CMV antibodies to detect shedding of the virus by culture in human foreskin fibroblasts, by detection of pp65 CMV-antigen and by a nested PCR assay. The prevalence of anti CMV-IgG antibodies was 76.6% (92/120), and IgM anti-CMV antibodies were detected in 13% (12/92) of the seropositive children. During the first viral evaluation, CMV was detected in the urine and/or saliva in 39/90 (43.3%) of the seropositive children. In the second and third evaluations, CMV was detected in 41/89 (46%) and in 35/89 (39.3%) children, respectively. Detection of CMV was shown both in urine and saliva in 28/39 (71.8%), 19/41(46.3%) and 20/35 (57.1%) of the children excreting the virus, respectively. Additionally, in 33/49 (67.4%) of the excreters CMV could be demonstrated in urine or saliva in at least two out of the three virological evaluations carried out sequentially in a six month period. Of the 28 initially seronegative children, 26 were re-examined for anti-CMV IgG antibodies about 18 months after the negative sample; seroconversion was found in 10/26 (38.5%). Taking all 536 samples of urine or saliva examined by virus culture and pp65 antigen detection during the study into account, 159 (29.6%) were positive by virus culture and 59 (11%) gave a positive result with the pp65 assay. These data demonstrate the high prevalence of CMV shedding and the high risk of CMV infection in children with Down syndrome attending a day-care center for mentally handicapped patients. The virus culture was more sensitive than the pp65 CMV antigen assay for CMV detection in both urine and saliva samples.
publishDate 2000
dc.date.none.fl_str_mv 2000-08-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/rimtsp/article/view/30436
url https://www.revistas.usp.br/rimtsp/article/view/30436
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/rimtsp/article/view/30436/32320
dc.rights.driver.fl_str_mv Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Paulo
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Paulo
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo
publisher.none.fl_str_mv Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo
dc.source.none.fl_str_mv Revista do Instituto de Medicina Tropical de São Paulo; Vol. 42 No. 4 (2000); 179-184
Revista do Instituto de Medicina Tropical de São Paulo; Vol. 42 Núm. 4 (2000); 179-184
Revista do Instituto de Medicina Tropical de São Paulo; v. 42 n. 4 (2000); 179-184
1678-9946
0036-4665
reponame:Revista do Instituto de Medicina Tropical de São Paulo
instname:Instituto de Medicina Tropical (IMT)
instacron:IMT
instname_str Instituto de Medicina Tropical (IMT)
instacron_str IMT
institution IMT
reponame_str Revista do Instituto de Medicina Tropical de São Paulo
collection Revista do Instituto de Medicina Tropical de São Paulo
repository.name.fl_str_mv Revista do Instituto de Medicina Tropical de São Paulo - Instituto de Medicina Tropical (IMT)
repository.mail.fl_str_mv ||revimtsp@usp.br
_version_ 1798951642788265984